G0S2 and glioblastoma: Segregating patients in the GSE13041 dataset by G0S2 expression revealed a statistically significant worse prognosis for GBM patients with high G0S2 (> 1.2 x median level) compared with those with low (< 1.2 x median level) (Fig. 1j).